Hims & Hers Health Inc.(HIMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HIMS Hims & Hers Health Inc.

Trading 06-24 12:23:01 EDT

33.30

+0.34

+1.02%

High33.74	Low31.62	Vol6.45M
Open32.50	D1 Closing32.96	Amplitude6.43%
Mkt Cap7.69B	Tradable Cap6.79B	Total Shares231.07M
T/O211.03M	T/O Rate3.16%	Tradable Shares204.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"HIMS","market":"US","secType":"STK","nameCN":"Hims & Hers Health Inc.","latestPrice":33.295,"timestamp":1782318180062,"preClose":32.96,"halted":0,"volume":6449910,"delay":0,"changeRate":0.010163834951456336,"floatShares":204000000,"shares":231071031,"eps":-0.09,"marketStatus":"Trading","change":0.335,"latestTime":"06-24 12:23:01 EDT","open":32.5,"high":33.74,"low":31.62,"amount":211026962.14665002,"amplitude":0.06432,"askPrice":33.31,"askSize":67,"bidPrice":33.28,"bidSize":40,"shortable":3,"etf":0,"ttmEps":-0.09,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1782331200000},"marketStatusCode":2,"adr":0,"exchange":"NYSE","adjPreClose":32.96,"preHourTrading":{"tag":"盘前","latestPrice":32.51,"preClose":32.96,"latestTime":"09:29 EDT","volume":95840,"amount":3168209.7152,"timestamp":1782307799093,"change":-0.45,"changeRate":-0.013653,"amplitude":0.025285},"postHourTrading":{"tag":"盘后","latestPrice":33.174,"preClose":32.96,"latestTime":"19:59 EDT","volume":342138,"amount":11282654.8163,"timestamp":1782259193058,"change":0.214,"changeRate":0.006493,"amplitude":0.012136},"volumeRatio":0.642226,"impliedVol":0.9373,"impliedVolPercentile":0.502},"requestUrl":"/m/hq/s/HIMS/tweets","defaultTab":"tweets","newsList":[{"id":"2645852702","title":"Hims & Hers CFO Oluyemi Okupe sells 18,197 common shares worth $619,043 under 10b5-1 plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2645852702","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645852702?lang=en_us&edition=fundamental","pubTime":"2026-06-24 06:40","pubTimestamp":1782254411,"startTime":"0","endTime":"0","summary":"Hims & Hers Health CFO Oluyemi Okupe sold 18,197 Class A shares on June 22 at an average $34.03.He exercised options for 6,376 shares at $5.01 the same day.Directly held stake ended at 284,321 shares; an additional 7,853 shares were held indirectly via a trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL64Qc8G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers CFO Oluyemi Okupe sells 18,197 common shares worth $619,043 under 10b5-1 plan","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","HIMS","HIMZ","BK4196","HIMY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192374995","title":"Movement Alert｜Hims & Hers Health Falls 5.01% in Pre-Market Trading, Proposed Securities Sale Filing Triggers Profit-Taking After Week-Long Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1192374995","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192374995?lang=en_us&edition=fundamental","pubTime":"2026-06-23 18:54","pubTimestamp":1782212061,"startTime":"0","endTime":"0","summary":"On June 23, Hims & Hers Health fell 5.01% in pre-market trading, trading at $31.83/share, with turnover of approximately $2.92 million.On the news front, the company recently filed a proposed...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185381542","title":"Movement Alert｜Hims & Hers Health Overnight Decline 5.01%, Proposed Securities Sale Filing Triggers Profit-Taking After Multi-Day Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1185381542","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185381542?lang=en_us&edition=fundamental","pubTime":"2026-06-23 13:49","pubTimestamp":1782193797,"startTime":"0","endTime":"0","summary":"On June 23, Hims & Hers Health declined 5.01% overnight, trading at $31.78/share, with turnover of $2.8088 million.On the news front, the company recently filed a proposed securities sale...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193490379","title":"Movement Alert｜Hims & Hers Health Falls 5.05% in Regular Trading, Proposed Securities Sale Filing Triggers Profit-Taking After Sharp Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1193490379","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193490379?lang=en_us&edition=fundamental","pubTime":"2026-06-23 00:36","pubTimestamp":1782146210,"startTime":"0","endTime":"0","summary":"On June 23, Hims & Hers Health declined 5.05% in regular trading, trading at $33.7/share, with turnover of $451 million.On the news front, the company recently filed a proposed sale of securities...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644103924","title":"Cboe data suggests bullish flow in Hims and Hers Health with shares up 11.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644103924","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644103924?lang=en_us&edition=fundamental","pubTime":"2026-06-19 04:45","pubTimestamp":1781815510,"startTime":"0","endTime":"0","summary":"Cboe data suggests bullish flow in Hims and Hers Health (HIMS), with shares up $3.67, or 11.49%, near $35.55. Options volume more than double the d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-hims-and-hers-health-with-shares-up-11-49-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-hims-and-hers-health-with-shares-up-11-49-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMZ","HIMY","HIYY","HIMS","BK4196","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644380030","title":"Living Longer Is Big Business. These Stocks Will Benefit. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2644380030","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644380030?lang=en_us&edition=fundamental","pubTime":"2026-06-19 02:15","pubTimestamp":1781806500,"startTime":"0","endTime":"0","summary":"Health is wealth goes the saying. Now it's an investment opportunity, too.The consumerization of healthcare is nothing new, but the pandemic turbocharged its widespread adoption. From telehealth appointments to digital patient portals and wearable trackers, many people began to treat their health like any other retail experience -- whether it's walking into a CVS Health MinuteClinic after doing some shopping, or trying  to estimate the out-of-pocket price for procedures with cost-estimator tools.The upshot is that longevity, i.e. not only living longer but being healthy for longer, could be big business for healthcare companies. TD Cowen analysts estimate that the total addressable market for longevity healthcare exceeds $250 billion, with beneficiaries spanning companies making biological breakthroughs to those using artificial intelligence.\"Tools to measure and screen health status--across blood-based testing, imaging, and wearable--have advanced meaningfully,\" writes lead analyst Da","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","IE0002141913.USD","LU1571399168.USD","BK4551","OWLT","LU0106261612.USD","MYGN","LU2065171402.SGD","LU0345770308.USD","TDOC","LU1983299246.USD","LU2211815571.USD","LU2210150020.SGD","BK4588","LU0234572021.USD","BK4533","LU1989763427.SGD","LU0882574055.USD","LU1989763690.USD","LU2125909593.SGD","LU0072461881.USD","LU1061106388.HKD","LU1721429402.USD","IE00B4R5TH58.HKD","BK4568","BK4581","LU1861559042.SGD","LU2133065610.SGD","IE00BKVL7J92.USD","LU0208291251.USD","BK4082","BK4534","LU0868494617.USD","IE00B19Z3581.USD","HIMZ","BK4121","LU0114720955.EUR","IE00BJJMRZ35.SGD","LU1323610961.USD","BK4566","LU0320765489.SGD","LU1691799644.USD","LU0354030438.USD","LU2237957811.SGD","LU1699723380.USD","IE0009355771.USD","LU2065171311.SGD","BK4550","SGXZ41872573.SGD","LU1023059063.AUD","NTRA","IE00BMPRXN33.USD","LU0354030511.USD","LU1064131342.USD","SG9999002232.USD","HIMS","LU1057294990.SGD","CVS","LU2089984988.USD","LU0122379950.USD","BTMD","HIYY","BK4196","IE00BMPRXR70.SGD","IE0002270589.USD","GB00BDT5M118.USD","LU0266013472.USD","BK4167","BK4548","LU0345770993.USD","GH","LU2324357040.USD","LU2065731478.USD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","LU1721429741.USD","BK4209","BK4585","IE00BJT1NW94.SGD","BK4504","LU2112291526.USD","LU2237957902.USD","BK4535","HIMY","LU2264538146.SGD","BFLY","LU2210149790.SGD","LU2065170008.USD","LU0432979614.USD","LU1059921491.USD","LU2095319765.USD","LU0006061336.USD","HMYY","BK4139","SGXZ23171101.USD","LU0070302665.USD","PLNT","CAVA","IE00BFTCPJ56.SGD","BK4567","DXCM","IE00B2B36J28.USD","LU0211331839.USD","LU0390134368.USD","SG9999002224.SGD","LU2468319806.SGD","QTRX","IE00BSNM7G36.USD","LU0170899867.USD","LU2125909247.SGD","LU0012050646.USD","IE00B7SZLL34.SGD","LU2065169927.USD","LU0963586101.USD","ABT","LU0162691827.USD","LU1914381329.SGD","LU0053671581.USD","LU1988902786.USD","BK4007","LU2433249047.HKD","LU1861558580.USD","BK4592","SG9999004303.SGD","LU0061475181.USD","BK4216","LU0058720904.USD","LU1923622614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644681087","title":"Hims & Hers Health Is Maintained at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2644681087","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644681087?lang=en_us&edition=fundamental","pubTime":"2026-06-18 23:49","pubTimestamp":1781797740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HIMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 18, 2026 11:49 ET (15:49 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HIMS","HIMZ","HMYY","HIYY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122673993","title":"Movement Alert｜Hims & Hers Health Rises 5.68% in Regular Trading, Goldman Sachs GLP-1 Market Upgrade and Sales Recovery Signal Fuel Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1122673993","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122673993?lang=en_us&edition=fundamental","pubTime":"2026-06-18 22:20","pubTimestamp":1781792447,"startTime":"0","endTime":"0","summary":"On June 18, Hims & Hers Health rose 5.68% in regular trading, trading at $34.05/share, with turnover of approximately $250 million. The stock extended its multi-session rebound driven by a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644877042","title":"U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis","url":"https://stock-news.laohu8.com/highlight/detail?id=2644877042","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644877042?lang=en_us&edition=fundamental","pubTime":"2026-06-18 15:14","pubTimestamp":1781766857,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Datadog, Jabil, PrologisJune 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Datadog, Jabil an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nL4N42Q0IZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMX","BTSG","NRIX","HIMS","DUK","EFX","MU","MAA","EGP","LU0342679015.USD","ILMN","TECH","BXP","FR","HIYY","CME","ANDE","NUE","PAYO","DDOG","AHR","PEP","MUD","BDSX","BIIB","LU2211815571.USD","CPT","LU1861215975.USD","CAG","LXP","HIMY","FROG","EPRT","GRDN","MUU","INDV","LU2236285917.USD","EXR","TXG","AJG","JBL","EFSC","HIMZ","ESS","MULL","PK","INTU","DOGD","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644977749","title":"Barclays Keeps Their Buy Rating on Hims & Hers Health (HIMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2644977749","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644977749?lang=en_us&edition=fundamental","pubTime":"2026-06-18 14:27","pubTimestamp":1781764020,"startTime":"0","endTime":"0","summary":"Barclays analyst Glen Santangelo maintained a Buy rating on Hims & Hers Health today and set a price target of $39.00. Santangelo covers the Health...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-keeps-their-buy-rating-on-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-keeps-their-buy-rating-on-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMZ","HIMY","BK4196","HIMS","HMYY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644727968","title":"Hims & Hers CTO Mohamed Elshenawy disposes of USD 1.42 million in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2644727968","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644727968?lang=en_us&edition=fundamental","pubTime":"2026-06-18 06:51","pubTimestamp":1781736670,"startTime":"0","endTime":"0","summary":"Hims & Hers Health CTO Mohamed Elshenawy acquired 282,597 Class A shares on June 15 via RSU vesting and settlement.Issuer withheld 151,534 shares at USD 30.17 to cover tax obligations tied to the vesting.Elshenawy sold 30,040 shares on June 17 at USD 31.5, leaving 101,023 shares beneficially owned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 17, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL4nYYlx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers CTO Mohamed Elshenawy disposes of USD 1.42 million in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","BK4196","HIMY","HMYY","HIYY","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133832127","title":"Movement Alert｜Hims & Hers Health Rises 5.04% in Regular Trading, Goldman Sachs GLP-1 Market Upgrade and Sales Recovery Signal Drive Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1133832127","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133832127?lang=en_us&edition=fundamental","pubTime":"2026-06-18 02:58","pubTimestamp":1781722692,"startTime":"0","endTime":"0","summary":"On June 18, Hims & Hers Health rose 5.04% in regular trading, trading at $32.87/share, with turnover of $486 million. The stock extended its recent strong rebound as multiple bullish catalysts...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644268147","title":"Hims & Hers price target raised to $39 from $29 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2644268147","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644268147?lang=en_us&edition=fundamental","pubTime":"2026-06-18 02:55","pubTimestamp":1781722542,"startTime":"0","endTime":"0","summary":"Barclays raised the firm’s price target on Hims & Hers (HIMS) to $39 from $29 and keeps an Overweight rating on the shares. A combination of weight...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hims-hers-price-target-raised-to-39-from-29-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hims-hers-price-target-raised-to-39-from-29-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMS","HMYY","HIMY","HIMZ","HIYY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644760359","title":"Hims & Hers Stands to Get a Big Chunk of the $2.2B Peptides Market -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2644760359","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644760359?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:19","pubTimestamp":1781641140,"startTime":"0","endTime":"0","summary":"That buzzy peptide market that Hims & Hers wants in on could be worth close to $2.2 billion next year for the telehealth industry, according to a new estimate. And the amount for Hims & Hers: $440 million, or about a fifth of the total.The numbers, from investment bank Leerink Partners, are based on sales estimates for seven peptides that a Food and Drug Administration panel will review in late July.Some peptides -- the building blocks of protein -- are already approved by the FDA for use in prescription weight-loss drugs like Ozempic and Wegovy.But the Leerink estimates are focused on peptides geared toward \"wellness-minded consumers,\" which have grown in popularity on social media for uses like healing injuries and promoting longevity. They often are taken by injection.This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HMYY","HIMS","BK4196","HIYY","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179483505","title":"Movement Alert｜Hims & Hers Health Rises 5.45% in Regular Trading, Goldman Sachs GLP-1 Market Upgrade and Sales Improvement Signals Fuel Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1179483505","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179483505?lang=en_us&edition=fundamental","pubTime":"2026-06-16 23:17","pubTimestamp":1781623078,"startTime":"0","endTime":"0","summary":"On June 16, Hims & Hers Health rose 5.45% in regular trading, reaching $31.83/share with turnover of approximately $290 million, reflecting sustained bullish momentum driven by multiple catalysts.On...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643751790","title":"BUZZ-U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood, Mobileye","url":"https://stock-news.laohu8.com/highlight/detail?id=2643751790","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643751790?lang=en_us&edition=fundamental","pubTime":"2026-06-16 19:34","pubTimestamp":1781609654,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood, Mobileye Workspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter:","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nL6N42O0S7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250504.SGD","SG9999002224.SGD","BK4539","SG9999002232.USD","BK4604","LU0054578231.USD","HIMY","QCOM","QCMD","NBP","LU0868494708.USD","HOOI","SG9999015952.SGD","LU0061475181.USD","LU1861558580.USD","LU1035775433.USD","HOOX","LU2247934214.USD","HOOZ","HODU","LU0079474960.USD","LU2065170008.USD","BK4598","BK4512","LU2106854487.HKD","BK4588","BK4127","LU1066051225.USD","LU1496350502.SGD","IE00BVYPNQ40.USD","SG9999015978.USD","SG9999015986.USD","BK4515","BK4605","HOOY","HOOW","HUN","LU1823568750.SGD","MAC","BK4612","BK4551","LU1861559042.SGD","LU1244550577.SGD","LU0868494617.USD","LU1066051811.HKD","BK4534","LU1261432733.SGD","HMYY","LU1069344957.HKD","HIYY","BK4561","BK4231","LU1046421795.USD","LU1917777945.USD","IE00BSNM7G36.USD","LU1066053197.SGD","LU1244550221.USD","BK4527","SG9999015945.SGD","HOOD","BK4157","BK4573","ALVO","QCML","BK4141","ROBN","BK4098","BK4554","BK4080","BK4124","GB00BDT5M118.USD","HIMS","LU2065169927.USD","HOOG","LU1244550494.USD","LU0942090050.USD","MBLY","BK4579","BK4139","BK4585","LU1119994496.HKD","LU1974910355.USD","LU1066051498.USD","LU2065171311.SGD","HIMZ","BK4196","HOII","HOYY","BK4532","BK4581","SG9999001424.SGD","LU1084165304.USD","BK4575","IE00BGHQDM52.EUR","LU0081259029.USD","IE00BVYPNP33.GBP","LU2065171402.SGD","QCMU","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643755609","title":"BUZZ-Leerink sees about $440 million peptide revenue chance for Hims & Hers","url":"https://stock-news.laohu8.com/highlight/detail?id=2643755609","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643755609?lang=en_us&edition=fundamental","pubTime":"2026-06-16 18:12","pubTimestamp":1781604749,"startTime":"0","endTime":"0","summary":"BUZZ-Leerink sees about $440 million peptide revenue chance for Hims & Hers** Leerink Partners stimates a ~$2.2 bln telehealth peptide market, translating to ~$440 mln revenue and about $70 mln in core profit opportunity for Hims & Hers HIMS.N ** Brokerage says narrower prescribing could halve the opportunity to ~$1.1 bln market, ~$220 mln revenue and about $25 mln in core profit** Says opportunity hinges on July FDA advisory panel weighing use of 7 peptides in compounding** Notes commercialization unlikely before end-2026, with meaningful upside seen from 2027 and beyond** Flags safety, efficacy and prescribing limits as key risks to uptake** Leerink rates stock “market perform”, sees near-term focus on GLP-1 profitability** Including session's move, stock down ~7% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nL4N42O0SL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","BK4196","HIMS","HIMZ","HIMY","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643786009","title":"Hims & Hers files initial beneficial ownership statement for new director Kofi Owusu Amoo-Gottfried","url":"https://stock-news.laohu8.com/highlight/detail?id=2643786009","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643786009?lang=en_us&edition=fundamental","pubTime":"2026-06-16 05:13","pubTimestamp":1781558033,"startTime":"0","endTime":"0","summary":"Hims & Hers Health filed a Form 3 naming Kofi Owusu Amoo-Gottfried as a director, dated June 11, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 15, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL3rt01s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","BK4196","HIYY","HIMZ","HMYY","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643278678","title":"Hims & Hers Health holds annual shareholder meeting, directors elected","url":"https://stock-news.laohu8.com/highlight/detail?id=2643278678","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643278678?lang=en_us&edition=fundamental","pubTime":"2026-06-16 05:03","pubTimestamp":1781557412,"startTime":"0","endTime":"0","summary":"Hims & Hers Health held its annual shareholder meeting on June 11, 2026.Shareholders selected nine directors to serve through the 2027 annual meeting.KPMG was ratified as independent registered public accounting firm for fiscal 2026.Shareholders passed a non-binding advisory vote on executive pay.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL7xRzWz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","HIYY","HIMY","BK4196","HIMZ","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643788944","title":"Moderately bullish activity in Hims and Hers Health with shares up 10.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643788944","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643788944?lang=en_us&edition=fundamental","pubTime":"2026-06-16 02:35","pubTimestamp":1781548537,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Hims and Hers Health (HIMS), with shares up $2.87, or 10.7%, near $29.69. Options volume running well above average ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-hims-and-hers-health-with-shares-up-10-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-hims-and-hers-health-with-shares-up-10-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMY","HIYY","HIMZ","BK4196","HMYY","HIMS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0473},{"period":"1month","weight":0.3878},{"period":"3month","weight":0.5816},{"period":"6month","weight":-0.0493},{"period":"1year","weight":-0.2149},{"period":"ytd","weight":0.0151}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0162},{"period":"3month","weight":0.1169},{"period":"6month","weight":0.0626},{"period":"1year","weight":0.2223},{"period":"ytd","weight":0.0758}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.098962},{"month":2,"riseRate":0.571429,"avgChangeRate":0.066017},{"month":3,"riseRate":0.428571,"avgChangeRate":0.011001},{"month":4,"riseRate":0.428571,"avgChangeRate":0.018546},{"month":5,"riseRate":0.428571,"avgChangeRate":0.15891},{"month":6,"riseRate":0.714286,"avgChangeRate":0.019104},{"month":7,"riseRate":0.666667,"avgChangeRate":0.073238},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.14623},{"month":9,"riseRate":0.5,"avgChangeRate":0.080437},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.073266},{"month":11,"riseRate":0.714286,"avgChangeRate":0.187933},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.001486}],"exchange":"NYSE","name":"Hims & Hers Health Inc.","nameEN":"Hims & Hers Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Hims & Hers Health Inc.(HIMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Hims & Hers Health Inc.(HIMS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Hims & Hers Health Inc.,HIMS,Hims & Hers Health Inc.股票,Hims & Hers Health Inc.股票老虎,Hims & Hers Health Inc.股票老虎国际,Hims & Hers Health Inc.行情,Hims & Hers Health Inc.股票行情,Hims & Hers Health Inc.股价,Hims & Hers Health Inc.股市,Hims & Hers Health Inc.股票价格,Hims & Hers Health Inc.股票交易,Hims & Hers Health Inc.股票购买,Hims & Hers Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Hims & Hers Health Inc.(HIMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Hims & Hers Health Inc.(HIMS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction